Fresenius Kabi recalls IV fluid after testing finds particulatesnews2022-03-08T13:32:26+00:00March 8th, 2022|Fierce Pharma|
Salix works with colorectal cancer charity to catch the ‘silent killer’ before it can strikenews2022-03-08T12:34:33+00:00March 8th, 2022|Fierce Pharma|
And, exhale: Relief for Optinose as delivery system hits primary endpoints in chronic sinusitis phase 3news2022-03-08T11:53:42+00:00March 8th, 2022|Fierce Pharma|
NuCana’s twist on chemo drug Gemzar fails in phase 3 againnews2022-03-08T11:46:05+00:00March 8th, 2022|Fierce Pharma|
Bottlenecks are slowing switch to GSK’s long-acting HIV injectable Cabenuva: cliniciannews2022-03-08T11:40:53+00:00March 8th, 2022|Fierce Pharma|
Fresenius nets NBA All-Star and transplant recipient Sean Elliot for kidney disease campaignnews2022-03-07T18:59:40+00:00March 7th, 2022|Fierce Pharma|
Fresenius nets NBA All-Star and transplant recipient Sean Elliott for kidney disease campaignnews2022-03-07T18:59:40+00:00March 7th, 2022|Fierce Pharma|
Bristol Myers Squibb’s Revlimid finally faces competition in the U.S. with Teva’s generic launchnews2022-03-07T16:18:15+00:00March 7th, 2022|Fierce Pharma|
Gilead drops unclear win for key Trodelvy breast cancer trial, poking holes in CEO’s oncology plannews2022-03-07T15:37:33+00:00March 7th, 2022|Fierce Pharma|
Ukraine pharma CEO urges the industry to rally behind his country on three frontsnews2022-03-07T15:29:04+00:00March 7th, 2022|Fierce Pharma|
